Table 3 Clinicopathological data and univariate survival analysis results of 303 patients submitted to pancreatectomy with portal vein and/or superior mesenteric vein resection
From: Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement
Variable | Patients (%) | Median survival (months) | p (univariate analysis) |
|---|---|---|---|
Age | 0.531 | ||
< 70 | 53.2 | 28.3 | |
≥ 70 | 46.8 | 24 | |
Sex | 0.094 | ||
Males | 54.5 | 25 | |
Females | 45.5 | 26 | |
Comorbidities | 0.058 | ||
No | 38.3 | 26 | |
Yes | 61.7 | 24 | |
Tumor size | 0.193 | ||
<30 mm | 37.3 | 28 | |
≥30 mm | 62.7 | 24 | |
Resection margin | 0.850 | ||
R0 | 73.3 | 27 | |
R1 | 26.7 | 23 | |
T stage | 0.506 | ||
1 | 0.7 | na | |
2 | 6.6 | 28 | |
3 | 86.1 | 24 | |
4 | 6.6 | 22 | |
Number of retrieved lymph nodes | 0.797 | ||
< 17 | 24.1 | 26 | |
≥ 17 | 75.9 | 24 | |
Number of metastatic lymph nodes | 0.0005 | ||
0–2 | 56.1 | 35 | |
≥ 3 | 43.9 | 22 | |
N stage | 0.0002 | ||
N0 | 29.4 | 46 | |
N1 | 70.6 | 23 | |
NR | 0.0005 | ||
0 | 29.4 | 43 | |
0.01–0.2 | 48.2 | 24 | |
0.21–0.4 | 16.2 | 17 | |
> 0.4 | 6.3 | 22 | |
LODDS | 0.0013 | ||
Lodds <−0.005 | 23.4 | 72 | |
−0.005 ≤ Lodds <0.012 | 24.8 | 32 | |
0.012 ≤ Lodds <0.026 | 26.1 | 22 | |
Lodds ≥0.026 | 25.7 | 22 |